A Retrospective Chart Review of Thirty Three Children Who Have Received Clinical Treatment With Either Romiplostim or Eltrombopag From 2009-2013

Weill Cornell Medicine (WCM)

Status: Completed

Conditions: Immune Thrombocytopenia

Study type: Observational

Funder types: Other

Identifiers

NCT01974232

1310014390

Details and patient eligibility

About

This is a retrospective analysis of children (≤21years old) who received clinical treatment with either Romiplostim or Eltrombopag at 2 medical centers from 2009-2013. The children included in this study were from Weill Medical College of Cornell University, New York, New York and Children's Hospital Orange County, Orange, California

Enrollment: 33 patients

Sex: All

Ages: 19 months to 21 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. All patients in this study had received prior treatments before the start of TPO treatment including corticosteroids, IVIG, IV anti-D, and/or Rituximab.

Exclusion criteria

1. Children who do not have ITP

Trial design

33 participants in 2 patient groups

Romiplostim group

Eltrombopag group